Cargando…

Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds

BACKGROUND: Cell‐based influenza vaccines can solve the problem of the frequent occurrence of egg adaptation–associated antigenic changes observed in egg‐based vaccines. Seed viruses for cell‐based vaccines can be prepared from clinical specimens by cell culture; however, clinical samples risk harbo...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Yuichi, Takahashi, Hitoshi, Trusheim, Heidi, Roth, Bernhard, Mizuta, Katsumi, Hirata‐Saito, Asumi, Ogane, Teruko, Odagiri, Takato, Tashiro, Masato, Yamamoto, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040968/
https://www.ncbi.nlm.nih.gov/pubmed/31651085
http://dx.doi.org/10.1111/irv.12694
_version_ 1783501097173778432
author Harada, Yuichi
Takahashi, Hitoshi
Trusheim, Heidi
Roth, Bernhard
Mizuta, Katsumi
Hirata‐Saito, Asumi
Ogane, Teruko
Odagiri, Takato
Tashiro, Masato
Yamamoto, Norio
author_facet Harada, Yuichi
Takahashi, Hitoshi
Trusheim, Heidi
Roth, Bernhard
Mizuta, Katsumi
Hirata‐Saito, Asumi
Ogane, Teruko
Odagiri, Takato
Tashiro, Masato
Yamamoto, Norio
author_sort Harada, Yuichi
collection PubMed
description BACKGROUND: Cell‐based influenza vaccines can solve the problem of the frequent occurrence of egg adaptation–associated antigenic changes observed in egg‐based vaccines. Seed viruses for cell‐based vaccines can be prepared from clinical specimens by cell culture; however, clinical samples risk harboring respiratory viruses other than influenza virus. Therefore, it is necessary to investigate the patterns of co‐infection in clinical samples and explore whether cell culture technology can selectively propagate influenza viruses from samples containing other respiratory viruses. METHODS: A total of 341 clinical specimens were collected from patients with influenza or influenza‐like illness and analyzed by ResPlex II assay to detect 18 respiratory viruses. The patterns of co‐infection were statistically analyzed with Fisher's exact test. The samples with double or triple infections were passaged in suspension MDCK cells (MDCK‐S), adherent MDCK cells (MDCK‐A), and LLC‐MK2D cells. Cell‐passaged samples were analyzed by ResPlex II assay again to investigate whether each cell line could amplify influenza viruses and eliminate other respiratory viruses. RESULTS: Double infections were detected in 8.5% and triple infections in 0.9% of the collected clinical specimens. We identified four pairs of viruses with significant correlation. For all samples with double and triple infection, MDCK‐S and MDCK‐A could selectively propagate influenza viruses, while eliminating all contaminating viruses. In contrast, LLC‐MK2D showed lower isolation efficiency for influenza virus and higher isolation efficiency for coxsackievirus/echovirus than MDCK‐S and MDCK‐A. CONCLUSIONS: Both MDCK‐S and MDCK‐A are considered suitable for the preparation of influenza vaccine seed viruses without adventitious agents or egg‐adaptation mutations.
format Online
Article
Text
id pubmed-7040968
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70409682020-03-01 Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds Harada, Yuichi Takahashi, Hitoshi Trusheim, Heidi Roth, Bernhard Mizuta, Katsumi Hirata‐Saito, Asumi Ogane, Teruko Odagiri, Takato Tashiro, Masato Yamamoto, Norio Influenza Other Respir Viruses Original Articles BACKGROUND: Cell‐based influenza vaccines can solve the problem of the frequent occurrence of egg adaptation–associated antigenic changes observed in egg‐based vaccines. Seed viruses for cell‐based vaccines can be prepared from clinical specimens by cell culture; however, clinical samples risk harboring respiratory viruses other than influenza virus. Therefore, it is necessary to investigate the patterns of co‐infection in clinical samples and explore whether cell culture technology can selectively propagate influenza viruses from samples containing other respiratory viruses. METHODS: A total of 341 clinical specimens were collected from patients with influenza or influenza‐like illness and analyzed by ResPlex II assay to detect 18 respiratory viruses. The patterns of co‐infection were statistically analyzed with Fisher's exact test. The samples with double or triple infections were passaged in suspension MDCK cells (MDCK‐S), adherent MDCK cells (MDCK‐A), and LLC‐MK2D cells. Cell‐passaged samples were analyzed by ResPlex II assay again to investigate whether each cell line could amplify influenza viruses and eliminate other respiratory viruses. RESULTS: Double infections were detected in 8.5% and triple infections in 0.9% of the collected clinical specimens. We identified four pairs of viruses with significant correlation. For all samples with double and triple infection, MDCK‐S and MDCK‐A could selectively propagate influenza viruses, while eliminating all contaminating viruses. In contrast, LLC‐MK2D showed lower isolation efficiency for influenza virus and higher isolation efficiency for coxsackievirus/echovirus than MDCK‐S and MDCK‐A. CONCLUSIONS: Both MDCK‐S and MDCK‐A are considered suitable for the preparation of influenza vaccine seed viruses without adventitious agents or egg‐adaptation mutations. John Wiley and Sons Inc. 2019-10-25 2020-03 /pmc/articles/PMC7040968/ /pubmed/31651085 http://dx.doi.org/10.1111/irv.12694 Text en © 2019 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Harada, Yuichi
Takahashi, Hitoshi
Trusheim, Heidi
Roth, Bernhard
Mizuta, Katsumi
Hirata‐Saito, Asumi
Ogane, Teruko
Odagiri, Takato
Tashiro, Masato
Yamamoto, Norio
Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds
title Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds
title_full Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds
title_fullStr Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds
title_full_unstemmed Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds
title_short Comparison of suspension MDCK cells, adherent MDCK cells, and LLC‐MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds
title_sort comparison of suspension mdck cells, adherent mdck cells, and llc‐mk2 cells for selective isolation of influenza viruses to be used as vaccine seeds
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040968/
https://www.ncbi.nlm.nih.gov/pubmed/31651085
http://dx.doi.org/10.1111/irv.12694
work_keys_str_mv AT haradayuichi comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT takahashihitoshi comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT trusheimheidi comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT rothbernhard comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT mizutakatsumi comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT hiratasaitoasumi comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT oganeteruko comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT odagiritakato comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT tashiromasato comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds
AT yamamotonorio comparisonofsuspensionmdckcellsadherentmdckcellsandllcmk2cellsforselectiveisolationofinfluenzavirusestobeusedasvaccineseeds